Pharvaris Ownership | Who Owns Pharvaris?
Pharvaris Ownership Summary
Pharvaris is owned by 98.74% institutional investors, 6.09% insiders. Fmr is the largest institutional shareholder, holding 10.05% of PHVS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.74% of its assets in Pharvaris shares.
PHVS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Pharvaris | 98.74% | 6.09% | -4.83% |
| Sector | Healthcare Stocks | 246.48% | 12.12% | -158.60% |
| Industry | Biotech Stocks | 384.82% | 11.76% | -296.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 6.57M | 10.05% | $227.03M |
| General atlantic | 6.55M | 10.03% | $226.53M |
| Foresite capital management iv | 4.78M | 7.32% | $165.24M |
| Venbio partners | 4.64M | 7.11% | $160.57M |
| Viking global investors lp | 3.65M | 5.59% | $126.33M |
| Eqt fund management s.a r.l. | 3.42M | 5.24% | $118.42M |
| Deerfield management company, l.p. (series c) | 3.38M | 5.17% | $116.74M |
| Bain capital life sciences investors | 2.68M | 4.10% | $92.52M |
| Wellington management group llp | 2.39M | 3.66% | $82.75M |
| Polar capital | 2.33M | 3.56% | $80.45M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Foresite capital management iv | 4.78M | 56.95% | $165.24M |
| Venbio partners | 4.64M | 30.92% | $160.57M |
| Eqt fund management s.a r.l. | 3.42M | 13.73% | $118.42M |
| 5am venture management | 797.60K | 9.58% | $27.58M |
| General atlantic | 6.55M | 7.79% | $226.53M |
| Saturn v capital management | 1.31M | 6.52% | $45.44M |
| Foresite capital management v | 664.14K | 6.34% | $22.97M |
| Bain capital life sciences investors | 2.68M | 5.50% | $92.52M |
| Patient square capital lp | 671.21K | 3.60% | $23.21M |
| Commodore capital lp | 1.43M | 2.93% | $49.28M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Polar capital | 2.33M | 0.19% | 1.55M |
| Tcg crossover management | 1.01M | 0.84% | 1.01M |
| Paradigm biocapital advisors lp | 1.84M | 1.30% | 772.58K |
| Point72 asset management | 1.64M | 0.06% | 634.18K |
| Dv equities | 482.52K | 2.39% | 482.52K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| General atlantic | 6.55M | 7.79% | -1.48M |
| Vr adviser | 674.60K | 0.95% | -1.37M |
| Commodore capital lp | 1.43M | 2.93% | -493.97K |
| Baker bros. advisors lp | - | - | -375.00K |
| Novo | 1.40M | 2.81% | -350.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 1.01M | 0.84% | 1.01M | $34.86M |
| Dv equities | 482.52K | 2.39% | 482.52K | $16.69M |
| Ecor1 capital | 235.00K | 0.40% | 235.00K | $8.13M |
| Walleye capital | 200.42K | 0.02% | 200.42K | $6.93M |
| Integral health asset management | 200.00K | 0.34% | 200.00K | $4.99M |
Sold Out
| Holder | Change |
|---|---|
| Daiwa securities group | -213.00 |
| Corecap advisors | -2.70K |
| Virtus etf advisers | -3.74K |
| Ghisallo capital management | -11.25K |
| Quadrature capital | -13.72K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 129 | 15.18% | 64,484,527 | 9.44% | 98 | 1.21% | 72 | 56.52% | 33 | -5.71% |
| Mar 31, 2026 | 112 | 3.70% | 58,921,412 | -0.20% | 99 | 1.11% | 46 | -35.21% | 35 | 105.88% |
| Dec 31, 2025 | 61 | -26.51% | 31,462,572 | -45.61% | 50 | 0.59% | 43 | -36.76% | 6 | -25.00% |
| Sep 30, 2025 | 82 | 43.86% | 57,719,608 | 28.45% | 105 | 1.55% | 68 | 161.54% | 7 | -53.33% |
| Jun 30, 2025 | 60 | 15.38% | 45,040,180 | 0.23% | 82 | 1.20% | 28 | 55.56% | 16 | 14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 1.91M | 2.74% | - |
| Fidelity Growth Compy Commingled Pl O | 1.24M | 2.29% | - |
| Polar Capital Healthcare Opports Inc | 1.46M | 2.08% | - |
| Fidelity Growth Company Fund | 1.37M | 1.96% | - |
| Fidelity Select Health Care | 800.00K | 1.14% | - |
| Polar Capital Biotech S Inc | 761.73K | 1.08% | - |
| Fidelity Small Cap Growth | 644.59K | 0.92% | - |
| T. Rowe Price Health Sciences | 438.89K | 0.63% | 157.07K |
| Fidelity Advisor Health Care I | 400.00K | 0.57% | - |
| Fidelity Growth Company K6 | 399.48K | 0.57% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Monges Viviane | - | Sell | $395.52K |
| Sep 22, 2026 | Schikan Johannes Gerardus Christiaan Petrus | - | Sell | $28.95K |
| Sep 21, 2026 | Nassif David W. | CFO / CLO | Sell | $218.80K |
| Sep 17, 2026 | Lu Peng | President | Sell | $3.50M |
| Sep 17, 2026 | Schikan Johannes Gerardus Christiaan Petrus | - | Sell | $7.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2027 Q1 | - | - |
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q2 | - | - |
PHVS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools